These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. Bertagnolli LN; Varriale J; Sweet S; Brockhurst J; Simonetti FR; White J; Beg S; Lynn K; Mounzer K; Frank I; Tebas P; Bar KJ; Montaner LJ; Siliciano RF; Siliciano JD Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32066-32077. PubMed ID: 33239444 [TBL] [Abstract][Full Text] [Related]
85. A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation. Turk G; Seiger K; Lian X; Sun W; Parsons EM; Gao C; Rassadkina Y; Polo ML; Czernikier A; Ghiglione Y; Vellicce A; Varriale J; Lai J; Yuki Y; Martin M; Rhodes A; Lewin SR; Walker BD; Carrington M; Siliciano R; Siliciano J; Lichterfeld M; Laufer N; Yu XG Ann Intern Med; 2022 Jan; 175(1):95-100. PubMed ID: 34781719 [TBL] [Abstract][Full Text] [Related]
86. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425 [TBL] [Abstract][Full Text] [Related]
87. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time. Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL; J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547 [TBL] [Abstract][Full Text] [Related]
88. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. Tobin NH; Learn GH; Holte SE; Wang Y; Melvin AJ; McKernan JL; Pawluk DM; Mohan KM; Lewis PF; Mullins JI; Frenkel LM J Virol; 2005 Aug; 79(15):9625-34. PubMed ID: 16014925 [TBL] [Abstract][Full Text] [Related]
89. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus. Kincer LP; Joseph SB; Gilleece MM; Hauser BM; Sizemore S; Zhou S; Di Germanio C; Zetterberg H; Fuchs D; Deeks SG; Spudich S; Gisslen M; Price RW; Swanstrom R Nat Microbiol; 2023 Feb; 8(2):260-271. PubMed ID: 36717718 [TBL] [Abstract][Full Text] [Related]
90. Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities. Rausch JW; Le Grice SFJ Curr HIV Res; 2020; 18(2):99-113. PubMed ID: 31889490 [TBL] [Abstract][Full Text] [Related]
91. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. Soriano-Sarabia N; Bateson RE; Dahl NP; Crooks AM; Kuruc JD; Margolis DM; Archin NM J Virol; 2014 Dec; 88(24):14070-7. PubMed ID: 25253353 [TBL] [Abstract][Full Text] [Related]
92. HIV infection dynamics and viral rebound: Modeling results from humanized mice. Guo T; Deng Q; Qiu Z; Rong L J Theor Biol; 2023 Jun; 567():111490. PubMed ID: 37054969 [TBL] [Abstract][Full Text] [Related]
93. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930 [TBL] [Abstract][Full Text] [Related]
94. HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs. De Scheerder MA; Vrancken B; Dellicour S; Schlub T; Lee E; Shao W; Rutsaert S; Verhofstede C; Kerre T; Malfait T; Hemelsoet D; Coppens M; Dhondt A; De Looze D; Vermassen F; Lemey P; Palmer S; Vandekerckhove L Cell Host Microbe; 2019 Sep; 26(3):347-358.e7. PubMed ID: 31471273 [TBL] [Abstract][Full Text] [Related]
95. Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice. Mu W; Zhen A; Carrillo MA; Rezek V; Martin H; Lizarraga M; Kitchen S J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282697 [TBL] [Abstract][Full Text] [Related]
96. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Rothenberger MK; Keele BF; Wietgrefe SW; Fletcher CV; Beilman GJ; Chipman JG; Khoruts A; Estes JD; Anderson J; Callisto SP; Schmidt TE; Thorkelson A; Reilly C; Perkey K; Reimann TG; Utay NS; Nganou Makamdop K; Stevenson M; Douek DC; Haase AT; Schacker TW Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1126-34. PubMed ID: 25713386 [TBL] [Abstract][Full Text] [Related]
97. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. Halvas EK; Joseph KW; Brandt LD; Guo S; Sobolewski MD; Jacobs JL; Tumiotto C; Bui JK; Cyktor JC; Keele BF; Morse GD; Bale MJ; Shao W; Kearney MF; Coffin JM; Rausch JW; Wu X; Hughes SH; Mellors JW J Clin Invest; 2020 Nov; 130(11):5847-5857. PubMed ID: 33016926 [TBL] [Abstract][Full Text] [Related]
98. Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice. Su H; Sravanam S; Gorantla S; Kaminski R; Khalili K; Poluektova L; Gendelman HE; Dash PK Front Cell Infect Microbiol; 2020; 10():38. PubMed ID: 32117811 [TBL] [Abstract][Full Text] [Related]
99. Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication. Pinkevych M; Docken SS; Okoye AA; Fennessey CM; Del Prete GQ; Pino M; Harper JL; Betts MR; Paiardini M; Keele BF; Davenport MP PLoS Pathog; 2023 Oct; 19(10):e1011660. PubMed ID: 37801446 [TBL] [Abstract][Full Text] [Related]
100. Is the Central Nervous System Reservoir a Hurdle for an HIV Cure? Mohammadzadeh N; Chomont N; Estaquier J; Cohen EA; Power C Viruses; 2023 Dec; 15(12):. PubMed ID: 38140626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]